Pharmaceutical

Tricaprilin by Cerecin for Infantile Spasm (West Syndrome): Likelihood of Approval

Tricaprilin is under clinical development by Cerecin and currently in Phase II for Infantile Spasm (West Syndrome).

Dec 27, 2024 - 06:00
Tricaprilin is under clinical development by Cerecin and currently in Phase II for Infantile Spasm (West Syndrome).
Read the original article

Tags:

Previous Article

KGYY-15 by Op-T-Mune for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Appr...

Next Article

Gene Therapy to Target GD2 for Oncology by Bristol-Myers Squibb for Osteosarcoma...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Volrustomig by AstraZeneca for Cervical Cancer: Likelih...

Dec 22, 2023

Laurus Labs and IIT Kanpur partner for new gene therapy products

Laurus Labs and IIT Kanpur partner for new gene therapy...

Jun 19, 2023

Opinion: The misguided reason why providers aren’t prescribing more buprenorphine for opioid use disorder

Opinion: The misguided reason why providers aren’t pres...

Jan 6, 2024